Where can I find MANE's financial statements?

Veradermics, Incorporated (MANE)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.

How much history is available for MANE?

Veradermics, Incorporated (MANE) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.

How often does MANE update its statements?

Veradermics, Incorporated files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.

MANE (Veradermics, Incorporated) is a recent IPO.

It began trading on February 4, 2026, giving it under six months of public history. Many charts and metrics below are sparse or empty until more price, financial, and analyst history accumulates — the affected sections are flagged individually so you can tell limited history from missing data.

MANE

Veradermics, Incorporated

NYSE·Biotechnology · Healthcare

$109.49$3.45+3.25%

After hours·$109.49+0.00%

Market cap$4.57B·Market closed·Jul 21 8:00 PM UTC

USD · values shown as reported

Line item	FY 2023	FY 2024	FY 2025
Revenue	$0.00	$0.00	$0.00
Gross profit	$0.00	$0.00	$0.00
Research & development	$14.97M	$23.28M+55.5%	$62.07M+166.6%
General & administrative	$2.35M	$3.50M+48.5%	$10.28M+194.2%
SG&A (combined)	$2.35M	$3.50M+48.5%	$10.28M+194.2%
Total operating expenses	$17.32M	$26.78M+54.6%	$72.35M+170.2%
Operating income	−$17.32M	−$26.78M−54.6%	−$72.35M−170.2%
Interest income	$870.00K	$481.00K−44.7%	$1.56M+224.7%
Interest expense	$36.00K	$585.00K+1,525.0%	—
Other income / (expense), net	$834.00K	$290.00K−65.2%	$2.35M+711.0%
Income before tax	−$16.49M	−$26.49M−60.6%	−$70.00M−164.3%
Net income	−$16.49M	−$26.49M−60.6%	−$70.00M−164.3%

EPS (basic)	−$0.08	−$0.14−70.9%	−$2.38−1,600.0%
EPS (diluted)	−$0.08	−$0.14−70.9%	−$2.38−1,600.0%
Weighted avg shares (basic)	201,334,354	201,334,354	35,077,084
Weighted avg shares (diluted)	201,334,354	201,334,354	35,077,084

EBITDA	−$16.45M	−$25.90M−57.4%	−$70.00M−170.2%

Frequently Asked Questions About MANE

Where can I find MANE's financial statements?: Veradermics, Incorporated (MANE)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.
How much history is available for MANE?: Veradermics, Incorporated (MANE) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.
How often does MANE update its statements?: Veradermics, Incorporated files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.